Editorial Board About Us

Male infertility

All articles from this key word are listed below.

Volume 3, Number 3 Review Articles

Current Management of Adolescent Varicocele

Treatment Update

Steven J Skoog Darius A Paduch

Varicocele Male infertility Varicocelectomy Testicular growth arrest Retroperitoneal ligation Microsurgical inguinal repair

Volume 15, Number 4 Review Articles

The Use of In Vitro Fertilization in the Management of Male Infertility: What the Urologist Needs to Know

Management Review

Daniel M Arnett Sahar M Stephens Randall B Meacham

Infertility affects approximately 10% to 20% of reproductive-age couples, many of whom may present initially to a urologist. Some couples may be treated medically to increase spontaneous conception rates; however, many will require more aggressive management with in vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI). IVF involves ovarian stimulation, oocyte retrieval, and fertilization outside of the body; ICSI involves injecting one sperm into the oocyte to promote fertilization. Here we provide a brief overview of IVF and ICSI along with a discussion of the risks involved to facilitate the counseling and care of the infertile couple. [Rev Urol. 2013;15(4):154-160 doi: 10.3909/riu0588] © 2014 MedReviews®, LLC

Male infertility In vitro fertilization Intracytoplasmic sperm injection

Volume 15, Number 3 Meeting Reviews

Best of the 2013 AUA Annual Meeting Part II

More Highlights From the 2013 American Urological Association Annual Meeting, May 4-8, 2013, San Diego, CA

Scott I Zeitlin Jacob Rajfer Ellen Shapiro

[Rev Urol. 2013;15(3):118-123 doi: 10.3909/riu2013AUA2] © 2013 MedReviews®, LLC

Febrile urinary tract infection Male infertility Exogenous testosterone therapy MicroTESE Klinefelter’s syndrome Variocele Vasectomy reversal Antibiotic resistance

Volume 18, Number 2 Review Articles

The Role of Estrogen Modulators in Male Hypogonadism and Infertility

Disease State Review

Jesse N Mills Jacob Rajfer Amarnath Rambhatla

Estradiol, normally considered a female hormone, appears to play a significant role in men in a variety of physiologic functions, such as bone metabolism, cardiovascular health, and testicular function. As such, estradiol has been targeted by male reproductive and sexual medicine specialists to help treat conditions such as infertility and hypogonadism. The compounds that modulate estradiol levels in these clinical conditions are referred to as selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs). In a certain subset of infertile men, particularly those with hypogonadism, or those who have a low serum testosterone to estradiol ratio, there is some evidence suggesting that SERMs and AIs can reverse the low serum testosterone levels or the testosterone to estradiol imbalance and occasionally improve any associated infertile or subfertile state. This review focuses on the role these SERMs and AIs play in the aforementioned reproductive conditions. [Rev Urol. 2016;18(2):66-72 doi: 10.3909/riu0711] © 2016 MedReviews®, LLC

Selective estrogen receptor modulator Aromatase inhibitor Male infertility Hypogonadism